1. Liu, Haiyu, Li, Ye, Li, Yunbo, Zhou, Lixiang, Bie, Li. 2017. STMN1 as a candidate gene associated with atypical meningioma progression. In Clinical neurology and neurosurgery, 159, 107-110. doi:10.1016/j.clineuro.2017.06.003. https://pubmed.ncbi.nlm.nih.gov/28622584/
2. Liao, Li, Zhang, Yin-Ling, Deng, Ling, Shao, Zhi-Min, Li, Da-Qiang. . Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer. In Cancer research, 83, 471-484. doi:10.1158/0008-5472.CAN-22-2709. https://pubmed.ncbi.nlm.nih.gov/36484700/
3. Zhang, Yubao, Wei, Shijie, Zhang, Qinxiang, Zhang, Yue, Sun, Changgang. 2024. Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis. In Phytomedicine : international journal of phytotherapy and phytopharmacology, 130, 155746. doi:10.1016/j.phymed.2024.155746. https://pubmed.ncbi.nlm.nih.gov/38763012/
4. Vicari, Hugo Passos, Coelho-Silva, Juan Luiz, Pereira-Martins, Diego A, Traina, Fabiola, Machado-Neto, João Agostinho. 2021. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells. In Investigational new drugs, 40, 438-452. doi:10.1007/s10637-021-01197-0. https://pubmed.ncbi.nlm.nih.gov/34837603/
5. He, Haiyan, Li, Zifeng, Lu, Jing, Qian, Maoxiang, Du, Juan. . Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma. In Clinical and translational medicine, 12, e757. doi:10.1002/ctm2.757. https://pubmed.ncbi.nlm.nih.gov/35297204/
6. Li, Jian, Hu, Guohuang, Kong, Fujiao, He, Jianfeng, Sun, Weijia. 2015. Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. In Pathology oncology research : POR, 21, 1013-20. doi:10.1007/s12253-015-9930-y. https://pubmed.ncbi.nlm.nih.gov/25791566/
智鼠故事 
